McMurry-Heath Michelle
SEC Form 4 insider trading activity
McMurry-Heath Michelle has filed 5 SEC Form 4 filings (6 transaction rows) across 2 companies, including BVS, RVTY, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jun 4, 2026.
On the most recent filing, McMurry-Heath Michelle is listed as Director at Bioventus Inc. Inside the rolling window, McMurry-Heath Michelle reported no open-market purchases and 3 open-market sales totaling $295K in BVS and RVTY. The largest disclosed transaction in the window is a sale of 17,701 BVS shares on Nov 7, 2025, worth $131K.
Companies traded
Other insiders at BVS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$295K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has McMurry-Heath Michelle made?
McMurry-Heath Michelle has filed 5 SEC Form 4 filings (6 transaction rows) across 2 companies, including BVS, RVTY since 2025.
Which companies does McMurry-Heath Michelle trade?
McMurry-Heath Michelle has filed SEC Form 4 disclosures for 2 companies, including BVS, RVTY.
When was McMurry-Heath Michelle's most recent SEC Form 4 filing?
McMurry-Heath Michelle's most recent SEC Form 4 filing on Tracefour is dated Jun 4, 2026.
What is McMurry-Heath Michelle's total buy and sell value in the current window?
Inside the rolling retention window, McMurry-Heath Michelle bought $0 and sold $295K based on SEC Form 4 filings.
What was McMurry-Heath Michelle's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 17,701 BVS shares on 2025-11-07, worth $131K, per SEC Form 4 filings.